Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    15721430 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Capecitabine in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cavity Cancer
Conditions: Ovarian Cancer;   Primary Peritoneal Cavity Cancer
Intervention: Drug: capecitabine

Study has passed its completion date and status has not been verified in more than two years.